SCHEMBL30425126

SCHEMBL30425126

Cn1c(N)nc2cc(-c3cn(Cc4ncc(-c5nnc(C(F)F)o5)cc4F)nn3)ccc21

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 20/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25215322 1.00 HDAC6 (0.37) HDAC6
SCHEMBL25215366 0.88 HDAC6 (0.46) HDAC6
SCHEMBL30425276 0.88 HDAC6 (0.46) HDAC6
SCHEMBL30424271 0.88 HDAC1 (0.39) HDAC6
SCHEMBL25254154 0.88 HDAC1 (0.39) HDAC6
SCHEMBL25214570 0.86 HDAC6 (0.49) HDAC6
SCHEMBL30425630 0.86 HDAC6 (0.49) HDAC6
SCHEMBL30425048 0.85 HDAC6 (0.50) HDAC6
SCHEMBL25215269 0.85 HDAC6 (0.50) HDAC6
SCHEMBL25387287 0.84 HDAC6 (0.37) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN claimed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN claimed
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback